MeSH D054218 - precursor t-cell lymphoblastic leukemia-lymphoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Sandoz | Nelarabine | Atriance | 2007-08-22 |
Clinical Trials
Historical Success Rate
Phase 1
68%27/40
Phase 2
3%1/33
Phase 3
50%1/2
Approved: 1Overall Success rate: 1%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use